Please Wait.....
Report
Poultry Vaccines - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts (2025 - 2030)
Market Report I 2025-09-01 I 114 Pages I Mordor Intelligence
Poultry Vaccines Market Analysis
The poultry vaccine market size reached USD 2.29 Billion in 2025 and is projected to climb to USD 3.56 billion by 2030, reflecting a 9.4% CAGR. The global poultry vaccine market continues its upward trajectory as regulatory reform converges with disease pressure to redefine producer priorities. A closer examination of the 2024 landscape shows that Infectious Bronchitis vaccines retain a 23.1 % disease-segment share, yet Avian Influenza preparations are poised to accelerate at a 9.4 % CAGR between 2025 and 2030. Every time producers update their biosecurity budgets, they now weigh the indirect cost of regulatory non-compliance against the direct cost of vaccination, a calculation that has begun to favor preventive immunization in most commercial models.
Global Poultry Vaccines Market Trends and Insights
Regulatory Push to Replace Antibiotics with Preventive Vaccination
Mounting antimicrobial-resistance concerns have prompted the US Food & Drug Administration's Center for Veterinary Medicine to intensify pre-approval scrutiny of in-feed drugs while formally encouraging vaccination as an alternative route to compliance . In parallel, the European Medicines Agency is phasing in residue-monitoring protocols that make antibiotic-free certification commercially valuable. Integrated producers are therefore renegotiating feed contracts to reflect lower antibiotic volumes, releasing working capital that is rapidly redeployed into biologics purchasing. The strategic benefit extends to export-oriented operators, who leverage vaccination records to streamline customs clearance and shorten cash-conversion cycles.
Rapid Expansion of Vertically-Integrated Broiler Operations in ASEAN
. South and Southeast Asia's vertically integrated broiler systems are scaling at an estimated 4 %-5 % per year through 2030. The operational insight emerging from the region is that integrators are beginning to specify vaccine serotypes directly in grow-out contracts, thereby transferring some biological-risk responsibility upstream to suppliers. This practice is quietly shifting the balance of power in price discussions from distributors toward international vaccine brands that can guarantee strain-specific supply continuity.
Emergence of Variant IBV Serotypes Undermining Existing Bronchitis Vaccines
Mutation of IBV strains hastens product obsolescence. Manufacturers with agile seed-strain update capabilities are capturing multiyear supply agreements, locking in share before slower rivals can reformulate. Data from regional labs highlight an uptick in cross-protection failures, driving integrators to diversify brand portfolios to de-risk supply continuity. This fragmentation rewards suppliers able to deliver multiplex diagnostics that pinpoint serotype prevalence in near-real time.
Other drivers and restraints analyzed in the detailed report include:
Increasing Incidences of Poultry and Zoonotic Diseases / Improvements in Vectored and Combination Vaccinations / Heightened Regulatory Review of Viral-Vector Vaccines in China /
For complete list of drivers and restraints, kindly check the Table Of Contents.
Segment Analysis
The 23% market share of Infectious Bronchitis vaccines in 2024 underscores their role as table stakes for commercial producers. Variant turnover forces suppliers into more frequent seed-stock updates than for most other poultry diseases. The operational takeaway is that vendors able to synchronize strain updates with integrator production cycles gain negotiating leverage on multiyear supply agreements.
Live attenuated offerings hold 36 % share today, but vector technologies are projected to expand at 9.8 % CAGR through 2030. An emerging pattern shows integrators treating vector vaccines as a hedge against tightening residue regulations, positioning them not only as a health product but also as a compliance instrument.
Breeder-flock vaccination commands 44.8 % of 2024 revenues. Because every vaccinated breeder protects multiple downstream generations, GCC sovereign food-security funds now evaluate vaccine spend in terms of protein-security ROI, effectively bundling biologics purchases into national resilience budgets.
The Poultry Vaccines Market Report Segments the Industry Into Disease Type (Infectious Bronchitis, and More), Technology (Live Attenuated Vaccines, and More), Application (Broiler, and More), Dosage Form (Liquid, and More), Route of Administration (Injectable, and More), End User (Poultry Farms, and More), Distribution Channel (Hospital, and More), and Geography. The Market Sizes and Forecasts are Provided in Terms of Value (USD).
Geography Analysis
North America retains a 34% market share in 2024. USDA indemnity payouts totaling USD 1.1 billion highlight the fiscal magnitude of HPAI . Insurers have begun to model policy premiums on whether a farm participates in USDA-approved vaccination programs, effectively turning vaccines into quasi-financial instruments that influence coverage costs.
Asia is the fastest-growing region with an 8 % CAGR outlook for 2025-2030. China's historic 73 % avian-influenza vaccination coverage has prompted local labs to develop accelerated viral-evolution monitoring systems. Those surveillance assets double as competitive intelligence, allowing regional manufacturers to iterate vaccines ahead of global peers.
Europe, Latin America, and the Middle East each display distinct triggers for vaccine uptake, from welfare regulations to export-market access requirements. Brazil's export-oriented producers increasingly view vaccination status as a tariff-mitigation tool, whereas GCC buyers fold vaccine clauses directly into long-term feed import contracts to ensure continuity of local protein supplies.
List of Companies Covered in this Report:
Zoetis / Boehringer Ingelheim / Merck & Co., Inc. (Merck Animal Health/MSD) / Ceva Sante Animale / Elanco Animal Health Inc. / Phibro Animal Health / HIPRA S.A. / Huvepharma EAD / Dechra Pharmaceuticals / Hester Biosciences Ltd. / Venkys (India) Ltd. / Biovac Ltd. / Indian Immunologicals / Ringpu Biologicals Co. Ltd. / Avimex Laboratorios, S.A. de C.V. / SAN Group / Nisseiken Co. Ltd. /
Additional Benefits:
The market estimate (ME) sheet in Excel format /
3 months of analyst support /
1 Introduction
1.1 Study Assumptions & Market Definition
1.2 Scope of the Study
2 Research Methodology
3 Executive Summary
4 Market Landscape
4.1 Market Overview
4.2 Market Drivers
4.2.1 Regulatory Push to Replace Antibiotics with Preventive Vaccination in US & EU Poultry Chains
4.2.2 Rapid Expansion of Vertically-Integrated Broiler Operations in ASEAN, Driving Bulk Vaccine Contracts
4.2.3 Increasing Incidences of Poultry and Zoonotic Diseases
4.2.4 Commercial Roll-out of Thermostable Live-Attenuated Vaccines Unlocking Sub-Saharan Demand
4.2.5 Improvements in Vectored and Combination Vaccinations
4.2.6 GCC Food-Security Funds Accelerating Spend on Comprehensive Breeder Flock Immunization
4.3 Market Restraints
4.3.1 Use of Counterfeit Products
4.3.2 Cold-Chain Expense & Vaccine Hesitancy Among African Smallholders
4.3.3 Emergence of Variant IBV Serotypes Undermining Existing Bronchitis Vaccines
4.3.4 Heightened Regulatory Review of Viral-Vector Vaccines in China Delaying Product Launches
4.4 Supply-Chain Analysis
4.5 Regulatory Scenario
4.6 Technological Outlook
4.7 Porter's Five Forces Analysis
4.7.1 Threat of New Entrants
4.7.2 Bargaining Power of Buyers
4.7.3 Bargaining Power of Suppliers
4.7.4 Threat of Substitutes
4.7.5 Intensity of Competitive Rivalry
5 Market Size & Growth Forecasts (Value, USD)
5.1 By Disease Type
5.1.1 Infectious Bronchitis
5.1.2 Avian Influenza
5.1.3 Newcastle Disease
5.1.4 Marek's Disease
5.1.5 Coccidiosis
5.1.6 Egg Drop Syndrome
5.1.7 Avian Encephalomyelitis
5.1.8 Other Diseases
5.2 By Technology
5.2.1 Live Attenuated Vaccines
5.2.2 Inactivated (Killed) Vaccines
5.2.3 Recombinant / Vector Vaccines
5.2.4 DNA & Sub-unit Vaccines
5.2.5 Other Technologies
5.3 By Application
5.3.1 Broiler
5.3.2 Layer
5.3.3 Breeder
5.4 By Dosage Form
5.4.1 Liquid
5.4.2 Freeze-Dried (Lyophilized)
5.4.3 Powder
5.5 By Route of Administration
5.5.1 Injectable
5.5.2 Intranasal
5.6 By End User
5.6.1 Poultry Farms
5.6.2 Veterinary Hospitals & Clinics
5.6.3 Research Institutes
5.7 By Distribution Channel
5.7.1 Hospital / Clinic Pharmacy
5.7.2 Farm Supply Stores
5.7.3 Online & Direct Sales
5.8 By Geography
5.8.1 North America
5.8.1.1 United States
5.8.1.2 Canada
5.8.1.3 Mexico
5.8.2 Europe
5.8.2.1 Germany
5.8.2.2 United Kingdom
5.8.2.3 France
5.8.2.4 Italy
5.8.2.5 Spain
5.8.2.6 Rest of Europe
5.8.3 Asia-Pacific
5.8.3.1 China
5.8.3.2 Japan
5.8.3.3 India
5.8.3.4 South Korea
5.8.3.5 Australia
5.8.3.6 Rest of Asia-Pacific
5.8.4 South America
5.8.4.1 Brazil
5.8.4.2 Argentina
5.8.4.3 Rest of South America
5.8.5 Middle East
5.8.5.1 GCC
5.8.5.2 South Africa
5.8.5.3 Rest of Middle East
6 Competitive Landscape
6.1 Market Concentration
6.2 Strategic Moves
6.3 Market Share Analysis
6.4 Company Profiles (includes Global-level Overview, Market-level Overview, Core Segments, Financials as available, Strategic Information, Market Rank/Share, Products & Services, Recent Developments)
6.4.1 Zoetis Inc.
6.4.2 Boehringer Ingelheim International GmbH
6.4.3 Merck & Co., Inc. (Merck Animal Health/MSD)
6.4.4 Ceva Sante Animale
6.4.5 Elanco Animal Health Inc.
6.4.6 Phibro Animal Health Corporation
6.4.7 HIPRA S.A.
6.4.8 Huvepharma EAD
6.4.9 Dechra Pharmaceuticals PLC
6.4.10 Hester Biosciences Ltd.
6.4.11 Venkys (India) Ltd.
6.4.12 Biovac Ltd.
6.4.13 Indian Immunologicals Ltd.
6.4.14 Ringpu Biologicals Co. Ltd.
6.4.15 Avimex Laboratorios, S.A. de C.V.
6.4.16 SAN Group
6.4.17 Nisseiken Co. Ltd.
7 Market Opportunities & Future Outlook
7.1 White-space & Unmet-Need Assessment
- Not Sure / Need Reassuring
- Confirm Content
-
Content is provided by our partners and every effort is made to make Market Report details as clear as possible. If you are not sure the exact content you require is included in this study you can Contact us to double check. To do this you can:
Use the ‘? ASK A QUESTION’ below the license / prices and to the right of this box. This will come directly to our team who will work on dealing with your request as soon as possible.
Write to directly on support@scotts-international.com with details. Please include as much information as possible including the name of report or link so our staff will be able to work on you request.
Telephone us directly on 0048 603 394 346 and an experienced member of team will be on hand to answer.
-
- Sample Pages
-
With the vast majority of our partners we can obtain Sample Pages to support your decision. This is something we can arrange without revealing your personal details.
It is important to note that we will not be able to provide you the exact data or statistics such as Market Size and Forecasts. Sample pages usually confirm the layout or the Categories included in Charts and Graphs, excluding specific data.
To ask for Sample Pages by contact us through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
-
- Check for Alternatives
-
Whilst we try to make our online platform as easy to use as possible there is always the possibility that a better alternative has not been found in your search.
To avoid this possibility Contact us through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346 and a Senior Team Member can review your requirements and send a list of possibilities with opinions and recommendations.
-
- Confirm Content
- Prices / Formats / Delivery
- Prices
-
All prices are set by our partners and should be exactly the same as those listed on their own websites. We work on a Revenue share basis ensuring that you never pay more than what is offered elsewhere.
Should you find the price cheaper on another platform we recommend you to Contact us as we should be able to match this price. You can Contact us though through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
-
- Discounts
-
As we work in close partnership with our Partners from time to time we can secure discounts and assist with negotiations, this is part of our personalised service to you.
Discounts can sometimes be arranged for speedily placed orders; multiple report purchases or Higher License purchases.
To check if a Discount is possible please Contact our experienced team through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
-
- Available Currencies
-
Most Market Reports on our platform are listed in USD or EURO based on the wishes of our Partners. To avoid currency fluctuations and potential price differentiations we do not offer the possibility to change the currency online.
Should you wish to pay in a different currency to that advertised online we do accept payments in USD, EURO, GBP and PLN. The price will be calculated based on the relevant exchange rate taken from our National Bank.
To pay in a different above currency to that advertised online please Contact our team and a quotation will be sent within a couple of hours with payment details.
-
- Licenses
-
License options vary from Partner to Partner as is usually based on the number of Users that will benefitting from the report. It is very important that License ordered is not breached as this could have potential negative consequences for you individually or your employer.
If you have questions or need confirmation about the specific license we recommend you to Contact us and a detailed explanation will be provided.
-
- Global Site License
-
The Global Site License is the most comprehensive license available. By selecting this license, the Market Report can be shared with other ‘Allowed Users’ and any other member of staff from the same organisation regardless of geographic location.
It is important to note that this may exclude Parent Companies or Subsidiaries.
If you have questions or need confirmation about the specific license we recommend you to Contact us and a detailed explanation will be provided.
-
- Formats
-
The most common format is PDF, however in certain circumstances data may be present in Excel format or Online, especially in the case of Database or Directories. In addition, for certain higher license options a CD may also be provided.
If you have questions or need clarification about the specific formats we recommend you to Contact us and a detailed explanation will be provided.
-
- Delivery
-
Delivery is fulfilled by our partners directly. Once an order has been placed we inform the partner by sharing the delivery email details given in the order process.
Delivery is usually made within 24 hours of an order being placed, however it may take longer should your order be placed prior to the weekend or if otherwise specified on the Market Report details page. Additionally, if details have been not fully completed in the Order process a delay in delivery is possible.
If a delay in delivery is expected you will be informed about it immediately.
-
- Shipping Charges
-
As most Market Reports are delivered in PDF format we almost never have to add additional Shipping Charges. If, however you are ordering a Higher License service or a specific delivery format (e.g. CD version) charges may apply.
If you are concerned about additional Shipping Charges we recommend you to Contact us to double check.
-
- Prices
- Ordering
- By Credit Card
-
We work in Partnership with PayU to ensure payments are made securely in a fast and effortless way. PayU is the e-payments division of Naspers.
Naspers operates in over 133 International Markets and ranks 3rd Globally in terms of the number of e-commerce customers served.
For more information on PayU please visit: https://www.payu.pl/en/about-us
-
- By Money Transfer
-
If you require an invoice prior to payment, this is possible. To ensure a speedy delivery of the Market Report we require all relevant company details and you agree to maximum payment terms of 30 days from receipt of order.
With our regular clients deliver of the Market Report can be made prior to receiving payment, however in some circumstances we may ask for payment to be received before arranging for the Market Report to be delivered.
-
- By Credit Card
- Security
- Website security
-
We have specifically partnered with leading International companies to protect your privacy by using different technologies and processes to ensure security.
Everything submitted to Scotts International is encrypted via SSL (Secure Socket Layer) and all personal information provided to Scotts International is stored on computer systems with limited access in controlled environments.
-
- Credit Card Security
-
We partner with PayU (https://www.payu.pl/en/about-us) to ensure all credit card payments are made securely in a fast and effortless way.
PayU offers 250+ various payment channels and eWallet services across 4 continents allowing buyers to pay electronically, whether on a computer or a mobile device.
-
- Website security